Compile Data Set for Download or QSAR
Report error Found 51 Enz. Inhib. hit(s) with all data for entry = 50019354
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618448(CHEMBL5428800)
Affinity DataKd:  0.110nMAssay Description:Binding affinity to human recombinant IDO1 assessed as dissociation constant measured for 60 sec by SPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50126143(Epacadostat | INCB-024360)
Affinity DataIC50: 19nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50126143(Epacadostat | INCB-024360)
Affinity DataIC50: 48nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618448(CHEMBL5428800)
Affinity DataIC50: 640nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618449(CHEMBL5405607)
Affinity DataIC50: 920nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618448(CHEMBL5428800)
Affinity DataIC50: 1.04E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618449(CHEMBL5405607)
Affinity DataIC50: 1.68E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618444(CHEMBL5409754)
Affinity DataIC50: 1.95E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618445(CHEMBL5405797)
Affinity DataIC50: 2.38E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618439(CHEMBL5425638)
Affinity DataIC50: 2.69E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618437(CHEMBL5410887)
Affinity DataIC50: 3.58E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618447(CHEMBL5403582)
Affinity DataIC50: 3.73E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618445(CHEMBL5405797)
Affinity DataIC50: 4.13E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618444(CHEMBL5409754)
Affinity DataIC50: 4.46E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618456(CHEMBL5414500)
Affinity DataIC50: 5.59E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618437(CHEMBL5410887)
Affinity DataIC50: 5.66E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618442(CHEMBL5425154)
Affinity DataIC50: 5.72E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618456(CHEMBL5414500)
Affinity DataIC50: 5.75E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618441(CHEMBL5411066)
Affinity DataIC50: 6.14E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618457(CHEMBL5406101)
Affinity DataIC50: 6.23E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618438(CHEMBL5414623)
Affinity DataIC50: 6.35E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618439(CHEMBL5425638)
Affinity DataIC50: 6.37E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618450(CHEMBL5425383)
Affinity DataIC50: 7.07E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618442(CHEMBL5425154)
Affinity DataIC50: 7.23E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618455(CHEMBL5396591)
Affinity DataIC50: 7.52E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618447(CHEMBL5403582)
Affinity DataIC50: 7.61E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618450(CHEMBL5425383)
Affinity DataIC50: 7.78E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618457(CHEMBL5406101)
Affinity DataIC50: 7.80E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618438(CHEMBL5414623)
Affinity DataIC50: 8.52E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618455(CHEMBL5396591)
Affinity DataIC50: 8.84E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618446(CHEMBL5425304)
Affinity DataIC50: 8.85E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618453(CHEMBL5403916)
Affinity DataIC50: 9.18E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618453(CHEMBL5403916)
Affinity DataIC50: 9.29E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618443(CHEMBL5432275)
Affinity DataIC50: 9.42E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618452(CHEMBL5424551)
Affinity DataIC50: 9.45E+3nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618441(CHEMBL5411066)
Affinity DataIC50: 9.81E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618440(CHEMBL5394414)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618446(CHEMBL5425304)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618443(CHEMBL5432275)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618436(CHEMBL5421092)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618440(CHEMBL5394414)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618454(CHEMBL5400548)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618451(CHEMBL5439657)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618452(CHEMBL5424551)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618451(CHEMBL5439657)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618458(CHEMBL5413855)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618454(CHEMBL5400548)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618458(CHEMBL5413855)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human recombinant IDO1 measured after 60 mins by fluorescence based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50618436(CHEMBL5421092)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Guilin Medical University

Curated by ChEMBL
LigandPNGBDBM50241727(L-1-methyl-tryptophan | (S)-2-amino-3-(1-methyl-1H...)
Affinity DataIC50: 1.47E+4nMAssay Description:Inhibition of IDO1 in IFN-gamma treated human HeLa cells incubated for 48 hrs by absorbance based analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: